PRGO · Perrigo Company plc
United States · RS rating 84 · As of 2026-11-03
| Price | 15.70 USD |
|---|---|
| 1-day change | -0.3% |
| RS rating (overall / 1M / 3M / 12M) | 84 / 80 / 89 / 35 |
| Stage | Advancing |
| Composite / Minervini / CANSLIM score | 47 / 68 / 39 |
| Industry group (rank) | Medical-Generic Drugs (136) |
| EPS growth Q/Q | +71.9% |
| Sales growth Q/Q | +6.3% |
| Distance from 52-week high | +23.5% |
| Market cap (USD) | $1.6B |